StockData
Passage BIO, Inc. logo

Passage BIO, Inc. (PASG) stock

PASGNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 5/30
$4.01+0.01 (+0.25%)

Close on Nov 12, 2026Market cap $12.90MP/E –Yield –

Passage BIO statistics

59 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings
–
Last ex-dividend date
No dividends
Fundamentals through
Sep 30, 2026
Share price as of
Nov 12, 2026

Valuation ratiosIndustry

Market Cap
$12.90M
$280.48M
Enterprise Value
-$7.26M
$148.62M
PB Ratio
258.07
2.05
P/TBV Ratio
258.07
2.29

Share statisticsIndustry

Shares Change (YoY)
1.18%
10.9%
Shares Change (QoQ)
0.00%
0.51%
Float
2M
49M
Shares Held by Insiders
27.6%
12.1%
Shares Held by Institutions
133.1%
56.4%

Short sellingIndustry

Short Interest
49,551
–
Short Interest Change
-28.1%
-0.76%
Short % of Float
2.13%
9.04%
Short % of Shares Outstanding
1.54%
6.30%
Days to Cover
3.99
5.13

Stock price statisticsIndustry

52-Week High
$20.00
–
52-Week Low
$3.29
–
20-Day Moving Average
$3.55
–
50-Day Moving Average
$4.12
–
200-Day Moving Average
$5.84
–
Average True Range (14)
$0.34
–
Price Change (1 Week)
15.9%
1.51%
Price Change (1 Month)
9.56%
-2.35%
Price Change (3 Months)
-12.6%
-21.1%
Price Change (6 Months)
-25.2%
-22.6%
Price Change (YTD)
-66.0%
-22.6%
Price Change (1 Year)
-47.9%
-20.7%
Price Change (3 Years)
-66.6%
-27.4%
Price Change (5 Years)
-97.7%
-77.3%
Average Volume (10 Days)
17,650
–
Average Volume (20 Days)
15,430
–
Average Volume (90 Days)
23,635
–
Relative Volume
0.53
0.79
Relative Strength Index (14)
55.5
44.7
Volatility (1 Year)
114.8%
80.4%
Beta (5 Years)
1.63
1.07

Returns on capitalIndustry

Return on Equity (ROE)
-212.3%
-51.2%
Return on Assets (ROA)
-69.7%
-40.6%
Return on Capital Employed (ROCE)
-70616.0%
-38.0%

Financial positionIndustry

Current Ratio
1.00
3.30
Quick Ratio
0.97
2.42

EfficiencyIndustry

Profits Per Employee
-$1.38M
-$683.67K
Employee Count
24
75
WACC
13.1%
10.1%

Income statement (TTM)Industry

Operating Income
-$35.31M
-$20.99M
Net Income
-$33.08M
-$21.61M
EBITDA
-$34.98M
-$16.85M
EPS (Diluted)
-$10.35
-$0.75

Balance sheetIndustry

Net Cash (Debt)
$20.16M
$17.46M
Net Cash Per Share
$6.27
$0.72
Equity (Book Value)
$50.00K
$53.27M
Book Value Per Share
$0.02
$1.50
Tangible Book Value
$50.00K
$26.82M
Working Capital
$50.00K
$79.47M

Cash flow (TTM)Industry

Operating Cash Flow
-$32.65M
-$12.27M

Dividends and yieldsIndustry

Earnings Yield
-256.4%
-20.8%

Scores and fair valueIndustry

Altman Z-Score
-54.03
0.30
Piotroski F-Score
2
4

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

PeriodPASGS&P 500DifferencePASG per yearS&P 500 per year
1 month-11.9%-2.7%−9.2 pts
3 months-12.6%-1.7%−10.9 pts
Year to date-66.0%+11.9%−77.9 pts
1 year-57.2%+12.0%−69.2 pts
3 years-66.6%+78.2%−144.8 pts-30.6%+21.2%
5 years-97.7%+73.2%−170.9 pts-53.0%+11.6%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

0M PASG shares were sold short on Oct 30, 2026, down 28.1% from the previous report, or 2.13% of the shares available to trade. At recent volumes it would take 4.0 days to buy them back. Over the last 20 sessions, 57.0% of the volume reported to FINRA was short selling.

Settlement dateShares shortChangeAvg. daily volumeDays to cover
Oct 30, 202649,551-28.1%12,4344.0
Oct 15, 202668,917-24.1%19,8363.5
Sep 30, 202690,840-6.4%24,7393.7
Sep 15, 202697,008-4.6%30,3153.2
Aug 31, 2026101,638-25.8%19,6005.2
Aug 14, 2026136,935-12.1%10,43513.1
Jul 31, 2026155,837+25.0%34,4564.5
Jul 15, 2026124,628+9.1%48,2392.6
Jun 30, 2026114,193+23.3%257,1271.0
Jun 15, 202692,581-24.1%36,1792.6
May 29, 2026121,984-25.0%33,5473.6
May 15, 2026162,626+12.1%87,5321.9

Ratios use trailing-twelve-month results and the latest balance sheet. How we calculate.

See a number that looks wrong?